Results 41 to 50 of about 4,514 (173)
Decreased Prevalence of Plasmodium Falciparum Resistance Markers to Amodiaquine Despite its wide Scale use as ACT Partner Drug in Zanzibar. [PDF]
, 2012 Zanzibar has recently undergone a rapid decline in Plasmodium falciparum transmission following combined malaria control interventions with artemisinin-based combination therapy (ACT) and integrated vector control.
Björkman, Anders +7 more
core +4 more sources
Scientific Reports, 2022 With its strong effect on vector-borne diseases, and insecticidal effect on mosquito vectors of malaria, inhibition of sporogonic and blood-stage development of Plasmodium falciparum, as well as in vitro and in vivo impairment of the P.
Lovepreet Singh +4 more
doaj +1 more source
Macromolecular 4-aminoquinoline compounds as potential antimalarial drugs [PDF]
, 2011 4-Aminoquinolines have a long and successful history as antimalarials as they have provided a number of useful antimalarials. P. falciparum, a causative organism of the most deadly form of human malaria, is generally slow to develop resistance to these ...
Aderibigbe, Atim Blessing
core
Memorias do Instituto Oswaldo Cruz, 1992 With the use of a simple formulary, field by health agents was ewstablished a monitoring programme for responses of P. falciparum to the antimalarial drugs.
José Maria de Souza
doaj +1 more source
Memorias do Instituto Oswaldo Cruz, 2006 There are wide variations in the threshold used to define in vitro resistance of Plasmodium falciparum to amodiaquine (AQ), probably due to differences in methodology and interpretation. In vitro susceptibility data of Colombian P.
Diego F Echeverry +3 more
doaj +1 more source
In vitro activity of immunosuppressive drugs against Plasmodium falciparum [PDF]
, 2014 Background Solid organ transplant recipients are particularly vulnerable for infectious diseases due to prolonged immunosuppressive treatment. Residents of endemic regions and travellers may be exposed to malaria and may, therefore, require prolonged ...
Felix Loetsch +6 more
core +2 more sources
New 4-aminoquinoline-based cholinesterase inhibitors
, 2021 Medical treatment of Alzheimer’s disease (AD) and related dementias is mainly based on improving the level of the neurotransmitter acetylcholine in the brain by inhibiting the enzymes involved in acetylcholine breakdown, acetylcholinesterase and butyrylcholinesterase.
Bosak, Anita +3 more
openaire +3 more sources
THE ACTIVITY OF 4-AMINOQUINOLINE AGAINST PLASMODIUM FALCIPARUM IN SOUTHERN IRAN
Iranian Journal of Public Health, 1973 The resistance of Plasmodium falciparum to 4-amioquinolines has been confirmed in parts of South America such as Venezuela, Colombia, Brazil and Panama since 1961. During 1968-1970, 147 P.
AV. Manouchehri +2 more
doaj
Frontiers in Molecular Biosciences, 2021 Hydroxychloroquine sulfate is one of an extensive series of 4-aminoquinolines with antimalarial activity. Moreover, it is used for the treatment of rheumatoid arthritis.
Thirupathi Dongala +8 more
doaj +1 more source
Amodiaquine failure associated with erythrocytic glutathione in Plasmodium falciparum malaria [PDF]
, 2007 Objective To establish the relationship between production of glutathione and the therapeutic response to amodiaquine (AQ) monotherapy in Plasmodium falciparum non-complicated malaria patients.
Lina Zuluaga +4 more
core +1 more source